Clinical trial
A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of…
NCT00387413 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00387413 |
|---|---|
| Title | A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers |
| Official title | A Double-blind, Double-dummy, Placebo-controlled, Incomplete Block, Two Period Crossover Study of the Histamine H3 Antagonist GSK189254 and Duloxetine in the Electrical Hyperalgesia Model of Central Sensitisation in Healthy Volunteers |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hyperalgesia |
| Intervention type | Drug |
| Interventions | Duloxetine, GSK189254, GSK189254 Placebo, Duloxetine Placebo |
| Enrollment | 40 |
| Start date | Oct 2, 2006 |
| Primary completion | May 31, 2007 |
| Completion | May 31, 2007 |
| First posted | Oct 13, 2006 |
| Last update posted | Aug 7, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: